Cardiovascular Risk Stratification in Patients With Obstructive Sleep Apnea
NCT ID: NCT00768625
Last Updated: 2008-10-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2000 participants
OBSERVATIONAL
2005-04-30
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. To determine the frequency of cardiovascular diseases in patients with OSA, obese, overweight, and lean (BMI\<25)
2. To analyze the CPAP treatment over the clinical evolution of OSA patients
3. To determine if OSA is a independent predictor of cardiovascular risk
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
30 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Associacao Fundo de Incentivo a Psicofarmcologia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AFIP
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fatima D Cintra, PhD
Role: PRINCIPAL_INVESTIGATOR
Associacao Fundo de Incentivo a Psicofarmcologia
Dalva Poyares, PhD
Role: STUDY_CHAIR
Associacao Fundo de Incentivo a Psicofarmcologia
Sergio Tufik, PhD
Role: STUDY_DIRECTOR
Associacao Fundo de Incentivo a Psicofarmcologia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Instituto do Sono/AFIP
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Fatima D Cintra, MD, PhD
Role: primary
Wercules Oliveira
Role: backup
References
Explore related publications, articles, or registry entries linked to this study.
Feres MC, Fonseca FA, Cintra FD, Mello-Fujita L, de Souza AL, De Martino MC, Tufik S, Poyares D. An assessment of oxidized LDL in the lipid profiles of patients with obstructive sleep apnea and its association with both hypertension and dyslipidemia, and the impact of treatment with CPAP. Atherosclerosis. 2015 Aug;241(2):342-9. doi: 10.1016/j.atherosclerosis.2015.05.008. Epub 2015 May 23.
Cintra FD, Tufik S, Paola Ad, Feres MC, Melo-Fujita L, Oliveira W, Rizzi C, Poyares D. Cardiovascular profile in patients with obstructive sleep apnea. Arq Bras Cardiol. 2011 Apr;96(4):293-9. doi: 10.1590/s0066-782x2011005000030. Epub 2011 Mar 18. English, Portuguese, Spanish.
Rizzi CF, Cintra F, Risso T, Pulz C, Tufik S, de Paola A, Poyares D. Exercise capacity and obstructive sleep apnea in lean subjects. Chest. 2010 Jan;137(1):109-14. doi: 10.1378/chest.09-1201. Epub 2009 Oct 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ERA
Identifier Type: -
Identifier Source: org_study_id